AbbVie Inc. is 67.7x more valuable than RHYTHM PHARMACEUTICALS, INC. by market capitalization ($397.44 B vs $5.87 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RYTM | ABBV |
|---|---|---|
| Market cap | $5.87 B | $397.44 B |
| US-listed rank | #1281 | #28 |
| Revenue (latest FY) | $189.76M | $61.16B |
| Net income (latest FY) | -$196.54K | $4.23B |
| Net margin | -0.1% | 6.9% |
| P/E (trailing FY) | - | 94.0 |
| SEC filings | 799 | 1,008 |
AbbVie Inc. is 67.7x more valuable than RHYTHM PHARMACEUTICALS, INC. by market capitalization ($397.44 B vs $5.87 B).
In their latest fiscal years, RHYTHM PHARMACEUTICALS, INC. reported $189.76M in revenue while AbbVie Inc. reported $61.16B.
Full pages: RHYTHM PHARMACEUTICALS, INC. and AbbVie Inc., or browse the full rankings.